Sign up to save your podcasts
Or
Share Healthegy's Medtech Conference Bringing Together Pols, VCs and Executives to Discuss Sector's Future
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Healthegy's Medtech Conference Bringing Together Pols, VCs and Executives to Discuss Sector's Future
Join us on Thursday at the Medtech Conference in Minneapolis to hear from Congressman Erik Paulsen.
A longtime proponent of the Medtech industry, Rep. Paulsen most recently co-authored a letter asking the Trump administration to remove medical technology products from a list of Chinese imports subject to protective tariffs.
The five-term Congressman also has fought against the Medical Device Tax.
The Medtech Conference co-chairs and advisory board also are pleased to honor Dave Amerson, CEO of NeoTract, as the recipient of this year’s Dealmaker of the Year Award.
The award recognizes Amerson's leadership of the urology start-up as it established its UroLift System as a critical treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
Sales of UroLift were surging when Teleflex agreed to acquire the company, paying $725 million up front with the promise of another $375 million in milestone payments over the next two years.
In an interview, Justin Klein, general partner of NEA, and Amerson will discuss:
Join us on May 31st to explore this singular successful story and to better understand our entire Medtech sector.
A longtime proponent of the Medtech industry, Rep. Paulsen most recently co-authored a letter asking the Trump administration to remove medical technology products from a list of Chinese imports subject to protective tariffs.
The five-term Congressman also has fought against the Medical Device Tax.
The Medtech Conference co-chairs and advisory board also are pleased to honor Dave Amerson, CEO of NeoTract, as the recipient of this year’s Dealmaker of the Year Award.
The award recognizes Amerson's leadership of the urology start-up as it established its UroLift System as a critical treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
Sales of UroLift were surging when Teleflex agreed to acquire the company, paying $725 million up front with the promise of another $375 million in milestone payments over the next two years.
In an interview, Justin Klein, general partner of NEA, and Amerson will discuss:
- The steps Neotract took to adopt a winning culture?
- What strategies helped the company secure support from payers, providers?
- How the deal with Teleflex came to be?
- What's next for Teleflex in Urology?
Join us on May 31st to explore this singular successful story and to better understand our entire Medtech sector.
View all episodes
By Healthegy
4.8
5959 ratings
Join us on Thursday at the Medtech Conference in Minneapolis to hear from Congressman Erik Paulsen.
A longtime proponent of the Medtech industry, Rep. Paulsen most recently co-authored a letter asking the Trump administration to remove medical technology products from a list of Chinese imports subject to protective tariffs.
The five-term Congressman also has fought against the Medical Device Tax.
The Medtech Conference co-chairs and advisory board also are pleased to honor Dave Amerson, CEO of NeoTract, as the recipient of this year’s Dealmaker of the Year Award.
The award recognizes Amerson's leadership of the urology start-up as it established its UroLift System as a critical treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
Sales of UroLift were surging when Teleflex agreed to acquire the company, paying $725 million up front with the promise of another $375 million in milestone payments over the next two years.
In an interview, Justin Klein, general partner of NEA, and Amerson will discuss:
Join us on May 31st to explore this singular successful story and to better understand our entire Medtech sector.
A longtime proponent of the Medtech industry, Rep. Paulsen most recently co-authored a letter asking the Trump administration to remove medical technology products from a list of Chinese imports subject to protective tariffs.
The five-term Congressman also has fought against the Medical Device Tax.
The Medtech Conference co-chairs and advisory board also are pleased to honor Dave Amerson, CEO of NeoTract, as the recipient of this year’s Dealmaker of the Year Award.
The award recognizes Amerson's leadership of the urology start-up as it established its UroLift System as a critical treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
Sales of UroLift were surging when Teleflex agreed to acquire the company, paying $725 million up front with the promise of another $375 million in milestone payments over the next two years.
In an interview, Justin Klein, general partner of NEA, and Amerson will discuss:
- The steps Neotract took to adopt a winning culture?
- What strategies helped the company secure support from payers, providers?
- How the deal with Teleflex came to be?
- What's next for Teleflex in Urology?
Join us on May 31st to explore this singular successful story and to better understand our entire Medtech sector.
More shows like Medtech Talk
View all
TED Radio Hour
21,957 Listeners
The Tim Ferriss Show
16,141 Listeners
Motley Fool Money
3,211 Listeners
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
534 Listeners
WSJ What’s News
4,327 Listeners
The Knowledge Project
2,699 Listeners
The a16z Show
1,093 Listeners
HBR IdeaCast
163 Listeners
How I Built This with Guy Raz
30,180 Listeners
Up First from NPR
56,489 Listeners
The Journal.
6,071 Listeners
Guy Kawasaki's Remarkable People
648 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,997 Listeners
Huberman Lab
29,193 Listeners
HBR On Leadership
164 Listeners